Cite
Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway.
MLA
Li, Jianliang, et al. “Myricitrin Promotes Osteogenesis and Prevents Ovariectomy Bone Mass Loss via the PI3K/AKT Signalling Pathway.” Journal of Cellular Biochemistry, vol. 124, no. 8, Aug. 2023, pp. 1155–72. EBSCOhost, https://doi.org/10.1002/jcb.30439.
APA
Li, J., Mai, J., Zhang, M., Ma, Y., He, Q., Gong, D., Xiao, J., Li, M., Chen, W., Li, Z., Chen, S., Pan, Z., Li, S., & Wang, H. (2023). Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway. Journal of Cellular Biochemistry, 124(8), 1155–1172. https://doi.org/10.1002/jcb.30439
Chicago
Li, Jianliang, Jiale Mai, Meng Zhang, Yanhuai Ma, Qi He, Dawei Gong, Jiacong Xiao, et al. 2023. “Myricitrin Promotes Osteogenesis and Prevents Ovariectomy Bone Mass Loss via the PI3K/AKT Signalling Pathway.” Journal of Cellular Biochemistry 124 (8): 1155–72. doi:10.1002/jcb.30439.